Ketorolac Effects on Post-operative Pain and Lumbar Fusion
Status:
NOT_YET_RECRUITING
Trial end date:
2026-08-01
Target enrollment:
Participant gender:
Summary
A double blind prospective randomized trial of IV Ketorolac vs. placebo in management of patients undergoing lumbar one or two level spinal fusions.
Primary objective
\- To demonstrate Ketorolac results in decreased postoperative opioid use following posterior spinal fusions during the first 48 hours.
Secondary objectives
* To demonstrate that the use of Ketorolac does not decrease spinal fusion in one or two level instrumented spinal fusions.
* To demonstrate the use of Ketorolac decreases the average length of stay following spinal fusions.